Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients

Figure 3

The serum levels sST2 in the effective group and ineffective group. (a) The sST2 levels were lower in the effective group than in the ineffective group; (b) patients in the effective group exhibited significantly lower sST2 levels post-SLIT than pre-SLIT; (c) no statistical difference was observed in the ineffective group between post-SLIT and pre-SLIT. (d) the change of sST2 levels was higher in the effective group than in the ineffective group. sST2: soluble suppressor of tumorigenicity 2; SLIT: sublingual immunotherapy.

(a)

(b)

(c)

(d)